Cargando…
Effects of a Soluble Guanylate Cyclase Stimulator Riociguat on Contractility of Isolated Pulmonary Artery and Hemodynamics of U46619-Induced Pulmonary Hypertension in Dogs
SIMPLE SUMMARY: Pulmonary hypertension (PH) is a progressive and refractory vascular disease in both dogs and humans. The soluble guanylate cyclase stimulator riociguat is a relatively novel pulmonary vasodilator used for the treatment of PH in human medicine. Although riociguat may have beneficial...
Autores principales: | Kameshima, Satoshi, Nakamura, Yuki, Uehara, Kenji, Kodama, Tomoko, Yamawaki, Hideyuki, Nishi, Kotaro, Okano, Shozo, Niijima, Ryo, Kimura, Yuya, Itoh, Naoyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960282/ https://www.ncbi.nlm.nih.gov/pubmed/36851463 http://dx.doi.org/10.3390/vetsci10020159 |
Ejemplares similares
-
Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension
por: Lian, Tian-Yu, et al.
Publicado: (2017) -
First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension
por: Spreemann, Till, et al.
Publicado: (2017) -
The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats
por: Lang, Michaela, et al.
Publicado: (2011) -
The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats
por: Lang, Michaela, et al.
Publicado: (2012) -
Riociguat, a soluble guanylate cyclase stimulator, ameliorates right ventricular contraction in pulmonary arterial hypertension
por: Murata, Mitsushige, et al.
Publicado: (2017)